摘要: Non-invasive techniques to diagnose genetic disease have advanced rapidly in recent years and include prenatal diagnosis for fetal aneuploidy single gene disorders, early screening people affected by cancer diabetes. In this chapter we consider some of the key ethical issues arising as a result new technology. We highlight how non-invasive testing offers number significant benefits patients including safe testing. Issues that been raised concerns erosion informed decision-making, pressure test, non-medical reasons or information only broader societal impact widespread introduction may have. These are should be considered when developing practice guidelines.
springer.com
sci-hub.se 参考文章(60)
C. Michael Osborne, Emily Hardisty, Patricia Devers, Kathleen Kaiser-Rogers, Melissa A. Hayden, William Goodnight, Neeta L. Vora, Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease Prenatal Diagnosis. ,vol. 33, pp. 609- 611 ,(2013) , 10.1002/PD.4100
Reana Tischler, Louanne Hudgins, Yair J. Blumenfeld, Henry T. Greely, Kelly E. Ormond, Noninvasive Prenatal Diagnosis: Pregnant Women’s Interest and Expected Uptake Prenatal Diagnosis. ,vol. 31, pp. 1292- 1299 ,(2011) , 10.1002/PD.2888
Elles M. J. Boon, Brigitte H. W. Faas, Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies Prenatal Diagnosis. ,vol. 33, pp. 563- 568 ,(2013) , 10.1002/PD.4111
Heather Skirton, Christine Patch, Factors affecting the clinical use of non-invasive prenatal testing: a mixed methods systematic review. Prenatal Diagnosis. ,vol. 33, pp. 532- 541 ,(2013) , 10.1002/PD.4094
Eric Wang, Annette Batey, Craig Struble, Thomas Musci, Ken Song, Arnold Oliphant, Gestational age and maternal weight effects on fetal cell‐free DNA in maternal plasma Prenatal Diagnosis. ,vol. 33, pp. 662- 666 ,(2013) , 10.1002/PD.4119
C. J. Searle, K. Smith, G. Daniels, E. J. Maher, O. Quarrell, Cell-free fetal DNA sex determination identified a maternal SRY gene with a known X chromosome deletion. Prenatal Diagnosis. ,vol. 33, pp. 612- 613 ,(2013) , 10.1002/PD.4078
Ashwin Agarwal, Lauren C. Sayres, Mildred K. Cho, Robert Cook-Deegan, Subhashini Chandrasekharan, Commercial landscape of noninvasive prenatal testing in the United States Prenatal Diagnosis. ,vol. 33, pp. 521- 531 ,(2013) , 10.1002/PD.4101
Onora O'Neill, Autonomy and Trust in Bioethics ,(2002)
Nicholas Lench, Angela Barrett, Sarah Fielding, Fiona McKay, Melissa Hill, Lucy Jenkins, Helen White, Lyn S. Chitty, The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made Prenatal Diagnosis. ,vol. 33, pp. 555- 562 ,(2013) , 10.1002/PD.4124
G. Ashoor, A. Syngelaki, E. Wang, C. Struble, A. Oliphant, K. Song, K. H. Nicolaides, Trisomy 13 detection in the first trimester of pregnancy using a chromosome‐selective cell‐free DNA analysis method Ultrasound in Obstetrics & Gynecology. ,vol. 41, pp. 21- 25 ,(2013) , 10.1002/UOG.12299